Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2013
At a glance
- Drugs Metformin (Primary) ; Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 25 Jan 2012 Actual patient number (49) added as reported by ClinicalTrials.gov.
- 25 Jan 2012 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.